Serial growth ultrasound, Doppler cascade & BPP/NST-guided delivery-timing protocol
Fetal growth restriction (FGR) is a fetus that has failed to reach its biologically determined growth potential, most commonly operationalized as an estimated fetal weight (EFW) or abdominal circumference (AC) below the 10th percentile for gestational age. Distinguishing pathologic FGR from a constitutionally small-for-gestational-age (SGA) fetus — and symmetric from asymmetric patterns — sets the entire downstream surveillance strategy.
SGA (small-for-gestational-age) is a purely statistical, population-based label: any fetus with EFW below the 10th percentile, most of whom are constitutionally small and healthy, following their own growth trajectory near a lower centile with normal Doppler studies and normal amniotic fluid.
FGR implies pathology — a fetus that is not reaching its own genetically determined growth potential because of an underlying uteroplacental, maternal, or fetal process. FGR fetuses carry the excess morbidity (hypoxia, acidemia, stillbirth) that SGA labeling alone does not capture.
Clinically, FGR is suspected when a low EFW/AC percentile is accompanied by abnormal Doppler indices, oligohydramnios, or a growth trajectory that crosses centiles downward on serial scans — features that separate the pathologically restricted fetus from the constitutionally small one.
Not every SGA fetus has FGR, and not every FGR fetus is below the 10th percentile at a single time point — a fetus crossing from the 60th to the 15th percentile over successive scans may already be growth-restricted despite an EFW still nominally "normal".
Symmetric (early-onset) FGR: head circumference, abdominal circumference, and femur length are all proportionately reduced. Onset is typically before 20–24 weeks, reflecting a global insult to cellular hyperplasia — commonly aneuploidy, structural malformation, or early congenital infection. The fetal brain is not spared because the process affects total cell number from the outset.
Asymmetric (late-onset) FGR: head circumference is relatively preserved while abdominal circumference lags — the classic "head-sparing" pattern. This reflects uteroplacental insufficiency arising later in pregnancy, after most cell hyperplasia is complete: the fetus redistributes cardiac output to protect the brain (brain-sparing) at the expense of abdominal viscera, subcutaneous fat, and the liver, which is the principal site of glycogen storage and a major contributor to abdominal circumference.
In practice, many cases show a mixed pattern, and the head-sparing / brain-sparing physiology itself becomes a Doppler-detectable sign (falling cerebroplacental ratio) later in the disease course.
Placental (most common): abnormal trophoblast invasion of the spiral arteries, uteroplacental insufficiency, placental infarcts, chronic villitis, confined placental mosaicism, and velamentous cord insertion. This is the dominant mechanism behind late-onset, asymmetric FGR and the driver of the Doppler cascade.
Maternal: chronic hypertension, preeclampsia, autoimmune disease (antiphospholipid syndrome, SLE), inherited or acquired thrombophilia, chronic renal disease, cyanotic cardiac disease, smoking, substance use, and severe malnutrition — all reduce uteroplacental perfusion or oxygen/nutrient delivery.
Fetal: aneuploidy (trisomy 18 and 13 particularly), structural anomalies, congenital infection (CMV, toxoplasmosis, rubella, Zika), and multiple gestation with unequal placental sharing — mechanisms that more often produce the early, symmetric pattern and warrant genetic and infectious work-up alongside Doppler assessment.
Because FGR is heterogeneous, an international Delphi procedure convened sonographers, maternal-fetal medicine specialists, and neonatologists to standardize definitions. The resulting 2016 consensus splits FGR into early-onset (<32 weeks) and late-onset (≥32 weeks) categories, each defined by a solitary criterion or a combination of contributory criteria — the framework this simulator uses to drive surveillance intensity.
Solitary criterion (either is sufficient alone): • AC or EFW <3rd percentile for gestational age • Absent end-diastolic flow (AEDF) in the umbilical artery
Contributory criteria (any combination, when neither solitary marker is present): • AC or EFW <10th percentile, combined with • Umbilical artery pulsatility index (UA-PI) >95th percentile, and/or • Uterine artery pulsatility index (UtA-PI) >95th percentile
Early-onset FGR is more strongly associated with placental disease overlapping preeclampsia, higher perinatal mortality, and a substantially longer expected surveillance window before a viable delivery gestational age is reached — which is why even isolated severe Doppler abnormality is treated as sufficient for diagnosis at this stage.
Early-onset FGR co-occurs with preeclampsia in roughly one-third to one-half of cases — the two conditions share the same upstream lesion of defective spiral artery remodeling and abnormal trophoblast invasion.
Solitary criterion: AC or EFW <3rd percentile alone is sufficient for diagnosis.
Contributory criteria — at least two of the following four are required when the solitary marker is absent: • AC or EFW <10th percentile • AC or EFW crossing more than two growth-chart quartiles on serial scans • Cerebroplacental ratio (CPR) <5th percentile • Umbilical artery pulsatility index (UA-PI) >95th percentile
Late-onset FGR is more common overall, has a milder and more insidious Doppler phenotype (UA-PI is often normal even when the fetus is compromised, making CPR and centile-crossing especially important), and is the category in which subtle placental insufficiency is easiest to miss without a structured growth-scan protocol.
The early/late distinction is not academic — it determines the entire trajectory of care:
• Early-onset FGR triggers referral to a maternal-fetal medicine unit, more intensive Doppler surveillance (including ductus venosus from diagnosis), detailed anatomy and karyotype/microarray review, and counseling anchored around extreme prematurity trade-offs.
• Late-onset FGR is managed with growth and Doppler surveillance but a shorter runway to term, and decision-making leans more heavily on cerebroplacental ratio and amniotic fluid because umbilical artery Doppler frequently stays within normal limits until late in the disease process.
Staging at diagnosis therefore sets the surveillance cadence, the threshold for admission, and the anticipated delivery window explored in later stages of this simulator.
Progressive uteroplacental insufficiency produces a predictable, sequential cascade of Doppler changes as the fetus first compensates for and then decompensates under chronic hypoxemia. Recognizing where a fetus sits on this cascade — from a mildly elevated umbilical artery pulsatility index to an abnormal ductus venosus a-wave — is the single most important skill in FGR surveillance.
As placental vascular resistance rises from progressive obliteration of tertiary stem villous arterioles, Doppler abnormalities appear in a broadly reproducible order:
1. Rising UA-PI: umbilical artery pulsatility index climbs above the 95th percentile as placental resistance increases — the earliest detectable sign. 2. Absent end-diastolic flow (AEDF): once roughly 30% or more of the placental vascular bed is obliterated, forward diastolic flow in the umbilical artery disappears. 3. Reversed end-diastolic flow (REDF): with further placental loss, diastolic flow reverses — blood flows backward toward the fetus during diastole, a high-risk state. 4. Brain-sparing / falling cerebroplacental ratio (CPR): the fetal brain vasodilates (falling MCA-PI) to preferentially redirect oxygenated blood, producing an abnormal (low) CPR = MCA-PI / UA-PI. 5. Ductus venosus a-wave reduction, then absence or reversal: the terminal, cardiovascular stage — reflecting rising right atrial and central venous pressure as myocardial performance fails under sustained hypoxemia and acidemia.
The ductus venosus is the single latest and most ominous marker in the cascade — an absent or reversed a-wave signals impending acidemia and myocardial decompensation, and in most protocols mandates delivery within 24–48 hours once the fetus is at a viable gestational age.
The cerebroplacental ratio (CPR) is calculated as MCA-PI ÷ UA-PI. A falling CPR — even before the umbilical artery becomes frankly abnormal — reflects the fetal circulatory adaptation known as brain-sparing: peripheral (splanchnic, renal, limb) vasoconstriction combined with cerebral vasodilation preserves oxygen and glucose delivery to the brain and heart at the expense of other organs.
An abnormal CPR (<5th percentile) is one of the four late-onset FGR contributory criteria precisely because it can detect placental compromise in fetuses whose umbilical artery Doppler remains deceptively normal — this is especially relevant for the late-onset, milder phenotype where UA-PI often stays within range.
Brain-sparing is adaptive in the short term but is associated with altered neurodevelopmental outcomes if sustained, which is one reason CPR abnormality alone can tip a delivery-timing decision even without frank umbilical artery Doppler abnormality.
The ductus venosus normally shows a triphasic waveform: a systolic (S) peak, a diastolic (D) peak, and a positive a-wave corresponding to atrial contraction, reflecting normal cardiac compliance and forward flow throughout the cardiac cycle.
As right ventricular afterload and central venous pressure rise under progressive hypoxemic-acidemic stress, the a-wave first flattens, then becomes absent, and finally reverses — blood is pushed backward into the ductus venosus during atrial contraction, a direct signal of severe right heart strain.
Because the ductus venosus reflects cardiac function rather than placental resistance directly, its abnormality typically lags umbilical artery changes by days to weeks, which is exactly why it is used as the final decision point for delivery timing rather than an early screening tool.
Surveillance frequency is not fixed — it escalates directly with Doppler severity, moving from routine fortnightly growth ultrasound toward twice-weekly and eventually daily biophysical profile (BPP) or non-stress testing (NST) as the fetus moves along the deterioration cascade. Corticosteroid administration must be timed against this same trajectory so the course completes before the anticipated delivery.
A structured intensification ladder, tied to Doppler category, is used across most maternal-fetal medicine protocols:
• Normal Doppler FGR: growth ultrasound every 2 weeks, umbilical artery Doppler and NST/BPP roughly weekly. • Elevated UA-PI (isolated): weekly Doppler and antenatal testing, growth every 2 weeks. • Absent end-diastolic flow (AEDF): twice-weekly BPP/NST and Doppler, with admission considered depending on gestational age and access to monitoring. • Reversed end-diastolic flow (REDF): daily BPP/NST and Doppler, generally inpatient. • Abnormal ductus venosus: continuous or twice-daily monitoring, with delivery planning treated as imminent rather than scheduled.
This stepwise intensification concentrates monitoring resources on the fetuses at greatest and most rapidly evolving risk, while avoiding unnecessary daily testing for stable, mildly affected pregnancies.
A complete course of antenatal corticosteroids (betamethasone or dexamethasone) accelerates fetal lung maturation and reduces neonatal respiratory distress syndrome, intraventricular hemorrhage, and mortality when delivery occurs preterm.
The course should be administered when delivery is anticipated within 7 days and gestational age is under 34 weeks (with some protocols extending a single "rescue" consideration up to 36+6 weeks in specific circumstances). Because FGR surveillance often reveals deterioration on a compressed timeline, corticosteroid timing must be anticipated proactively — for example, initiating steroids as soon as AEDF is identified in a fetus near the periviable-to-early-preterm window, rather than waiting for REDF or DV abnormality to appear.
Coordinating steroid timing with the surveillance cascade avoids the two failure modes: administering steroids too early (their benefit window is time-limited) or too late (delivery occurring before the course completes).
Because ductus venosus abnormality can precede delivery by only 24–48 hours in many protocols, corticosteroids are generally given proactively once reversed end-diastolic flow (REDF) is identified in a potentially viable, preterm fetus — waiting for DV changes risks missing the steroid window entirely.
The biophysical profile (BPP) scores five components, 2 points each (maximum 10): non-stress test reactivity, fetal breathing movements, gross body movements, fetal tone, and amniotic fluid volume. A modified BPP (NST plus amniotic fluid index only) is often used for more frequent surveillance, reserving the full BPP for confirmatory or less frequent assessment.
Oligohydramnios (part of the BPP) is itself a marker of chronic uteroplacental insufficiency, as fetal renal perfusion falls under redistribution physiology, reducing urine output and amniotic fluid volume — reinforcing the same pathophysiology driving the Doppler cascade.
A BPP score of ≤4/10, or an abnormal Doppler category, generally prompts delivery regardless of the calendar-based gestational age target, since these findings indicate the fetus may already be in a state of evolving compromise.
The delivery-timing decision synthesizes gestational age, Doppler category, BPP score, and corticosteroid status into a single recommendation that balances the risk of iatrogenic prematurity against the risk of stillbirth or hypoxic injury from continued expectant management. Trial evidence (notably TRUFFLE) and consensus guidance (ACOG/SMFM, RCOG) converge on gestational-age thresholds tied to Doppler severity.
Guidance converges on gestational-age windows that shorten as Doppler severity worsens, reflecting the accelerating risk of stillbirth relative to the (also falling) marginal risk of prematurity as gestational age advances:
• Normal Doppler indices with isolated FGR: deliver at 37 weeks 0 days to 38 weeks 6 days. • Isolated elevated UA-PI (diastolic flow still present): deliver around 37 weeks. • Absent end-diastolic flow (AEDF): deliver around 33–34 weeks, once corticosteroids (if indicated) are complete. • Reversed end-diastolic flow (REDF): deliver around 30–32 weeks. • Abnormal ductus venosus or other signs of decompensation (abnormal BPP, non-reassuring NST): deliver by approximately 30–32 weeks, or sooner if findings are severe and the fetus has reached a viable gestational age.
At every threshold, the decision is individualized: a reassuring BPP and stable serial Dopplers may support extending surveillance briefly to gain corticosteroid benefit, while a deteriorating trend accelerates delivery regardless of the calendar target.
The TRUFFLE trial (2015) showed that using ductus venosus changes (rather than cardiotocography short-term variation alone) as the trigger for delivery in early-onset FGR allowed pregnancies to continue roughly 4 days longer on average, without worsening — and in some analyses improving — neurodevelopmental outcome at 2 years, while still recognizing decompensation before overt fetal compromise.
Every delivery-timing decision in FGR is a trade-off between two opposing risk curves: the risk of stillbirth or hypoxic-ischemic injury from continued expectant management (which rises as Doppler status worsens) against the risk of complications of prematurity (which falls as gestational age advances).
Below approximately 26 weeks, especially with early-onset FGR and severe Doppler abnormality, counseling must be highly individualized, incorporating estimated fetal weight, parental wishes, and local neonatal intensive care outcomes data, since survival and intact-survival rates change rapidly across this gestational window.
Above roughly 34 weeks, the calculus shifts decisively toward delivery once significant Doppler abnormality (AEDF or worse) is present, because neonatal outcomes at this gestational age are overwhelmingly favorable relative to the ongoing risk of stillbirth from a failing placenta.
Fetuses with abnormal umbilical artery Doppler (AEDF/REDF) tolerate labor poorly because they have minimal physiologic reserve; cesarean delivery is frequently favored for REDF or abnormal ductus venosus, while a trial of labor may be reasonable with milder Doppler abnormality and reassuring continuous fetal monitoring.
Delivery planning should always include neonatology involvement in advance for anticipated preterm or growth-restricted infants, given the elevated risk of hypoglycemia (limited glycogen reserve), hypothermia (reduced subcutaneous fat), polycythemia (chronic fetal hypoxemia driving erythropoietin), and, in the most severely affected fetuses, need for immediate respiratory support.
Documenting the Doppler trajectory, BPP results, and corticosteroid timing in the delivery summary also informs postnatal placental pathology review, which frequently confirms the placental lesion (e.g., maternal vascular malperfusion) suspected antenatally.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Normal Doppler, EFW <10th %ile | 37 wks 0 d – 38 wks 6 d | No significant placental resistance elevation on serial UA-PI | Full-term neonatal outcomes expected |
| Isolated elevated UA-PI | ~37 weeks | Forward diastolic flow preserved, resistance rising | Low prematurity risk at this GA |
| Absent end-diastolic flow (AEDF) | 33–34 weeks | ~30%+ placental vascular bed obliterated | Steroid course completed prior if possible |
| Reversed end-diastolic flow (REDF) | 30–32 weeks | Retrograde diastolic flow, high-risk state | TRUFFLE-aligned inpatient monitoring window |
| Abnormal ductus venosus / decompensation | ~30 wks or sooner | Absent/reversed a-wave signals cardiac strain, impending acidemia | Delivery generally within 24–48 h once viable |